Bio-Gate AG (XTER:BIG1) Scaled Net Operating Assets : 0.36 (As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bio-Gate AG's operating assets for the quarter that ended in Jun. 2024 was €3.93 Mil. Bio-Gate AG's operating liabilities for the quarter that ended in Jun. 2024 was €2.05 Mil. Bio-Gate AG's Total Assets for the quarter that ended in Dec. 2023 was €5.26 Mil. Therefore, Bio-Gate AG's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.36.

Bio-Gate AG Scaled Net Operating Assets Historical Data

The historical data trend for Bio-Gate AG's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Scaled Net Operating Assets Chart

Bio-Gate AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.45

0.39

0.56

0.51

0.34

Bio-Gate AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.41	0.55	0.49	0.41	0.36

Competitive Comparison of Bio-Gate AG's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Bio-Gate AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Gate AG's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Gate AG's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Bio-Gate AG's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Bio-Gate AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bio-Gate AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(3.932	-	1.808)	/	6.219
=	0.34

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5.259	-	1.327
=	3.932

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.808	-	0	-	0
=	1.808

Bio-Gate AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(3.928	-	2.053)	/	5.259
=	0.36

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4.404	-	0.476
=	3.928

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.053	-	0	-	0
=	2.053

Bio-Gate AG Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Bio-Gate AG's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Gate AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

BIG1:Germany

Address

Neumeyerstrasse 28-34, Nurnberg, DEU

Website

http://www.biogate.de

Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.

Executives

Karl Richter

Supervisory Board

Bio-Gate AG Headlines

No Headlines